{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T21:11:14Z","timestamp":1768252274348,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:00:00Z","timestamp":1672876800000},"content-version":"am","delay-in-days":369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jinf.2021.10.017","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T22:06:49Z","timestamp":1635458809000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Efficacy of antibiotic short course for bloodstream infections in acute myeloid leukemia patients with febrile neutropenia: A retrospective comparative study"],"prefix":"10.1016","volume":"84","author":[{"given":"Agathe","family":"Metais","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Miguel","family":"Torregrosa Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Pilar","family":"Gallego Hernanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxime","family":"Pichon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Desmier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"France","family":"Roblot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9346-5848","authenticated-orcid":false,"given":"Blandine","family":"Rammaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2021.10.017_bib0001","unstructured":"World Health Organization, Global Action Plan on Antimicrobial Resistance. Geneva 2015 ; available from: \u201chttps:\/\/www.who.int\/publications\/i\/item\/9789241509763\u201d ; (accessed November 2nd, 2021)"},{"key":"10.1016\/j.jinf.2021.10.017_bib0002","unstructured":"J. O'Neill, 2016 - AMR review : tackling drug-resistant infections globally: final report and recommendations. available from: \u201chttps:\/\/amr-review.org\/sites\/default\/files\/160525_Final%20paper_with%20cover.pdf\u201d (accessed November 2nd, 2021)"},{"issue":"4","key":"10.1016\/j.jinf.2021.10.017_bib0003","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2021.10.017_bib0004","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijantimicag.2007.06.012","article-title":"Bacteraemia in febrile neutropenic cancer patients","volume":"30","author":"Klastersky","year":"2007","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"10.1016\/j.jinf.2021.10.017_bib0005","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1469-0691.2005.01297.x","article-title":"Piperacillin\u2013tazobactam monotherapy in high-risk febrile and neutropenic cancer patients","volume":"12","author":"Viscoli","year":"2006","journal-title":"Clin Microbiol Infect"},{"issue":"suppl 4","key":"10.1016\/j.jinf.2021.10.017_bib0006","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jac\/41.suppl_4.13","article-title":"Science and pragmatism in the treatment and prevention of neutropenic infection","volume":"41","author":"Klastersky","year":"1998","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"10.1016\/j.jinf.2021.10.017_bib0007","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s00277-018-3341-6","article-title":"Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria","volume":"97","author":"Cattaneo","year":"2018","journal-title":"Ann Hematol"},{"issue":"3","key":"10.1016\/j.jinf.2021.10.017_bib0008","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/jac\/dkq494","article-title":"Bacteraemia due to multidrug-resistant gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes","volume":"66","author":"Gudiol","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2021.10.017_bib0009","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijid.2018.03.022","article-title":"Bloodstream infections in cancer patients. risk factors associated with mortality","volume":"71","author":"Islas-Mu\u00f1oz","year":"2018","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2021.10.017_bib0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1200\/JOP.18.00269","article-title":"Optimal management of neutropenic fever in patients with cancer","volume":"15","author":"Zimmer","year":"2019","journal-title":"J Oncol Pract"},{"issue":"12","key":"10.1016\/j.jinf.2021.10.017_bib0011","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.3324\/haematol.2013.091330","article-title":"Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European conference on infections in leukemia (ECIL-4, 2011)","volume":"98","author":"Averbuch","year":"2013","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.jinf.2021.10.017_bib0012","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.medmal.2017.01.007","article-title":"Proposal for shorter antibiotic therapies","volume":"47","author":"Wintenberger","year":"2017","journal-title":"Med Mal Infect"},{"issue":"12","key":"10.1016\/j.jinf.2021.10.017_bib0013","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3324\/haematol.2013.091025","article-title":"European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European conference on infections in leukemia","volume":"98","author":"Averbuch","year":"2013","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.jinf.2021.10.017_bib0014","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/clinids\/11.6.954","article-title":"Risk of infectious complications in patients taking glucocorticosteroids","volume":"11","author":"Stuck","year":"1989","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.jinf.2021.10.017_bib0015","unstructured":"EUCAST: clinical breakpoints and dosing of antibiotics. available from: \"https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/v_11.0_Breakpoint_Tables.pdf\" (accessed November 2nd, 2021)"},{"issue":"5","key":"10.1016\/j.jinf.2021.10.017_bib0016","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00277-013-1965-0","article-title":"Relapsing bloodstream infections during treatment of acute leukemia","volume":"93","author":"Cattaneo","year":"2014","journal-title":"Ann Hematol"},{"issue":"2","key":"10.1016\/j.jinf.2021.10.017_bib0017","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/MD.0b013e31819dd0cf","article-title":"Recurrent Escherichia coli bloodstream infections: epidemiology and risk factors","volume":"88","author":"Sanz-Garc\u00eda","year":"2009","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.jinf.2021.10.017_bib0018","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00277-013-1872-4","article-title":"Incidence, risk factors, and outcome of bacteremia following autologous hematopoietic stem cell transplantation in 720 adult patients","volume":"93","author":"Pi\u00f1ana","year":"2014","journal-title":"Ann Hematol"},{"issue":"6","key":"10.1016\/j.jinf.2021.10.017_bib0019","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1055\/s-0031-1287838","article-title":"Bloodstream infections in paediatric cancer patients. Prospective comparative study in 2 university hospitals","volume":"223","author":"Krenn","year":"2011","journal-title":"Klin Padiatr"},{"issue":"6","key":"10.1016\/j.jinf.2021.10.017_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199531","article-title":"Risk factors for mortality in patients with acute leukemia and bloodstream infections in the era of multiresistance","volume":"13","author":"Garcia-Vidal","year":"2018","journal-title":"PLOS ONE"},{"issue":"1","key":"10.1016\/j.jinf.2021.10.017_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the infectious diseases society of America","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.jinf.2021.10.017_bib0022","doi-asserted-by":"crossref","first-page":"R267","DOI":"10.1186\/cc10545","article-title":"Duration of antibiotic therapy for bacteremia: a systematic review and meta-analysis","volume":"15","author":"Havey","year":"2011","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.jinf.2021.10.017_bib0023","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13063-015-0688-z","article-title":"Bacteremia antibiotic length actually needed for clinical effectiveness (BALANCE): study protocol for a pilot randomized controlled trial","volume":"16","author":"Daneman","year":"2015","journal-title":"Trials"},{"issue":"5","key":"10.1016\/j.jinf.2021.10.017_bib0024","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-038300","article-title":"Bacteremia antibiotic length actually needed for clinical effectiveness (BALANCE) randomised clinical trial: study protocol","volume":"10","author":"Daneman","year":"2020","journal-title":"BMJ Open"},{"issue":"7","key":"10.1016\/j.jinf.2021.10.017_bib0025","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/23744235.2018.1438649","article-title":"Early discontinuation of empirical antibacterial therapy in febrile neutropenia: the antibiostop study","volume":"50","author":"Le Clech","year":"2018","journal-title":"Infect Dis"},{"issue":"12","key":"10.1016\/j.jinf.2021.10.017_bib0026","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1016\/S2352-3026(17)30211-9","article-title":"Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial","volume":"4","author":"Aguilar-Guisado","year":"2017","journal-title":"Lancet Haematol"},{"issue":"5","key":"10.1016\/j.jinf.2021.10.017_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.02495-18","article-title":"A systematic review and meta-analysis of antibiotic treatment duration for bacteremia due to enterobacteriaceae","volume":"63","author":"Tansarli","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.jinf.2021.10.017_bib0028","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s10096-019-03467-5","article-title":"Short- versus long-course therapy in gram-negative bacilli bloodstream infections","volume":"38","author":"Sousa","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.jinf.2021.10.017_bib0029","doi-asserted-by":"crossref","first-page":"S201","DOI":"10.1093\/ofid\/ofu052.422","article-title":"714gram negative bacteremia: are shorter courses of antimicrobial therapy feasible?","volume":"1","author":"Swamy","year":"2014","journal-title":"Open Forum Infect Dis."},{"issue":"6","key":"10.1016\/j.jinf.2021.10.017_bib0030","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/tropej\/fml054","article-title":"Randomized controlled trial of 7-day vs. 14-day antibiotics for neonatal sepsis","volume":"52","author":"Chowdhary","year":"2006","journal-title":"J Trop Pediatr"},{"issue":"11","key":"10.1016\/j.jinf.2021.10.017_bib0031","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1093\/cid\/ciz223","article-title":"Antibiotic therapy for Pseudomonas aeruginosa bloodstream infections: how long is long enough?","volume":"69","author":"Fabre","year":"2019","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445321005326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445321005326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:32:50Z","timestamp":1759008770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445321005326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0163445321005326"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2021.10.017","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of antibiotic short course for bloodstream infections in acute myeloid leukemia patients with febrile neutropenia: A retrospective comparative study","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2021.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}